Panel maker InnoLux has been expanding its presence in the medical field in recent years, and its subsidiary InnoCare Optoelectronics announced its third quarterly financial report on the 25th.

In the third quarter, InnoCare's revenue was NT$481 million, an increase of 3.96% QoQ, gross margin was 32.32%, an increase of 1.66 percentage points QoQ, profit margin was 5.85%, an increase of 1.72 percentage points QoQ, net income after tax was NT$61.6 million, a decrease of 16.36% QoQ, and net income per share was NT$4.87. In the first three quarters, InnoCare's revenue was NT$1.411 billion, gross margin was 29.97%, profit margin was 4%, and net income after tax was NT$171 million. Net income after tax was NT$171 million and net income per share was NT$4.87.

The company's business covers X-ray flat panel detector components and X-ray flat panel detector modules, mainly for medical applications. The products have been certified by the US Food and Drug Administration (FDA), the European Union (CE) and the Taiwan Food and Drug Administration (TFDA).

The market expects that InnoCare will be listed on the Emerging Stock Exchange by the end of this year at the earliest, and the chairman of InnoCare will be Yang Chu-Chiang (楊柱祥) and the president will be Lee Chi-Sheng (李志聖).

More informaiton please visit www.innocare-x.com